T. Rowe Price Associates
BSTG

T. Rowe Price Associates’s Biostage, Inc. Common Stock BSTG Stock Holding History

T. Rowe Price Associates’s Portfolio BSTG Stock Details BSTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-28,250
Closed -$40K – 2561
2015
Q2 		$40K Buy
28,250
+2,000
+8% +$4.9K ﹤0.01% 2509
2015
Q1 		$85K Hold
26,250
– – ﹤0.01% 2482
2014
Q4 		$83K Hold
26,250
– – ﹤0.01% 2485
2014
Q3 		$213K Buy
26,250
+16,200
+161% +$133K ﹤0.01% 2308
2014
Q2 		$105K Buy
+10,050
New +$85.6K ﹤0.01% 2455

Other funds holding BSTG

State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $29.3B AUM 38.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
WIC
Woodmont Investment Counsel Nashville, Tennessee $1.83B AUM 25.91% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

T. Rowe Price Associates's BSTG Position: Q3 2015 in Review

T. Rowe Price Associates sold out of Biostage, Inc. Common Stock (BSTG) in Q3 2015, closing a stake of 28,250 shares — an estimated $40K sold.

T. Rowe Price Associates first reported a position in BSTG in Q2 2014 and held it in 5 quarters. The position peaked at $213K in Q3 2014. 30 funds tracked by Wall St. Rank hold BSTG as of Q3 2015.

  • T. Rowe Price Associates reported no remaining Biostage, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • T. Rowe Price Associates sold 28,250 Biostage, Inc. Common Stock shares in Q3 2015, an estimated $40K.
  • T. Rowe Price Associates first reported a position in Biostage, Inc. Common Stock in Q2 2014 and held it in 5 quarters.
  • T. Rowe Price Associates's Biostage, Inc. Common Stock position peaked at $213K in Q3 2014.
  • 30 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q3 2015.

Based on T. Rowe Price Associates's 13F filing for Q3 2015, filed 13 Nov 2015.